Can exposure to body odors be used to enhance a mindfulness treatment for social anxiety?

Not Applicable

Completed

• Conditions: Social anxiety symptoms; Mental and Behavioural Disorders

• Registration Number: ISRCTN11342305
• Lead Sponsor: Karolinska Institutet

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2023-12-18
• Study Completion: 2024-06-30
• Last Update Posted: 8 July 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 133

Inclusion Criteria

1. Aged between 18 and 35 years old
2. Female gender
3. A score over 30 on the Liebowitz Social Anxiety Scale in its self-report formulation (LSAS-SR)
4. A confirmation of the disorder during a face-to-face interview (SCID 5-CV)
5. Normosmic as screened with Sniffin’ Stick test
6. No pregnancy
7. Non-smokers

Exclusion Criteria

1. Chronic rhinitis or other conditions that may affect the ability to perceive odors
2. Breastfeeding
3. Presence of other mental disorders (including substance abuse disorders) apart from major depression, chronic depression, minor depression, or dysphoria and social anxiety disorder
4. Presence of any severe somatic or neurological conditions
5. Use of psychotropic drugs at the moment of the recruitment (including antidepressants, antipsychotics, anxiolytics and mood stabilizers)
6. Presently undergoing psychological therapy,
7. Presence of severe psychotic symptoms (i.e., hallucinations and/or delusions)
8. Presence of suicidal thoughts
9. Incapability to understand and to give an informed consent for the experiment

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Anxiety symptoms measured using the State-Trait Anxiety Inventory (STAI) at baseline, pre-treatment (after the beginning of the stress induction) and post-treatment of day 1, at pre-treatment, post-treatment and after the end of the stress induction of day 2, and during day 3